Protein tyrosine phosphatase-α (PTPα) plays an important role in various cellular signaling events, including proliferation and differentiation. In this study, we established 
INTRODUCTION
Protein tyrosine phosphorylation plays a critical role in regulating various cellular events, including cell proliferation and differentiation (1) . Protein tyrosine kinases and protein tyrosine phosphatases (PTPs) function dynamically to maintain cellular homeostasis (2, 3) . PTPs catalyze the hydrolysis of phosphoryl groups on Tyr residues in proteins. Two classes of PTPs have been identified, the receptor-like, membrane-spanning PTPs, which may act as receptors, and the cytosolic PTPs characterized as intracellular low molecular weight enzymes (1) . PTPα is a member of the receptor-like PTP family with a relatively short (123 a.a.) extracellular domain that is highly glycosylated (4) . Like most transmembrane PTPs, PTPα has two homologous cytoplasmic catalytic domains; the domain proximal to the cell membrane, which exhibits the majority of protein-tyrosine phosphatase activity, and the second domain, which has low but detectable phosphatase activity (5, 6) .
PTPα is widely expressed in mammalian tissues and has been implicated in a variety of signaling pathways. It has been suggested that PTPα plays an important role in regulating insulin signaling. In baby hamster kidney cells, PTPα appeared to be a negative regulator thus allowing PTPα to dephosphorylate pTyr527, and thereby specifically activating Src (20) .
PTPα has been shown to play a role in both cellular differentiation and cellular transformation. Thus overexpression of PTPα in rat embryo fibroblasts caused transformation, while in P19 embryonal carcinoma cells this induced neuronal differentiation (15, 16) .
Both actions were associated with Src pTyr527 dephosphorylation and increased Src activity (21, 22) . In addition, overexpression of PTPα enhanced the development of neurotransmitter response during neuronal differentiation (23) and an upregulated expression of PTPα was observed during differention of ES cells into a neuronal phenotype (24) .
Differentiation of skeletal muscle precursor cells is a highly ordered multistep process initiated in response to a number of environmental signals (25) . Extensive studies of this process have demonstrated that it involves expression of muscle regulatory factors, withdrawal from the cell cycle, induction of muscle-specific gene expression, and changes of the cytoskeleton into specialized structures. Morphologically, muscle differentiation is characterized by cell alignment, elongation, fusion, and formation of multinucleated myotubes. This process is accompanied by an increase in the expression of muscle specific proteins such as myogenin, myosin heavy chain (MHC), and creatine kinase (25) . Some hormones and growth factors, in particular IGF-I (26, 27) and insulin (28) , appear to stimulate differentiation through various signal transduction pathways.
Thus, activation of both phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase is associated with and appears to be required for muscle differentiation (29) (30) (31) .
On the other hand, the specific noncompetitive inhibitor of MEK (MAPK kinase), PD098059, partially inhibited the fusion of myoblasts to multinucleated myotubes without affecting the expression of muscle-specific markers (32) .
In this study, L6 cells were transfected with either PTPα antisense, with full length human or mouse wild type or double catalytic site Cys to Ala phosphatase-dead mutant Cell Culture -L6 cells were grown and maintained as myoblasts in α-Minimal Essential Medium (α-MEM) supplemented with 10% fetal bovine serum (FBS) and 1%
antibiotic/antimycotics in an atmosphere of 5% CO 2 at 37ºC as described (35) .
Transfected cells were maintained as above with the addition of 400 µg/ml G418. Statistics -Results are expressed as means ± S.E., and the Student's t-test or analysis of variance was used to evaluate significance which was taken as a minimum of p < 0.05. were grown on glass cover slips and stained with rabbit polyclonal antibody against PTPα. As shown in Fig. 1D , PTPα was widely distributed but more concentrated in the perinuclear area. There was no nuclear staining. The intensity of staining of PTPα in AS14 was markedly decreased when compared to that in L6, whereas it was much higher in M4 than that in L6 consistent with the immunoblot results (Fig. 1D) .
RESULTS

Expression of PTPα in L6 Cells
Effects of Expression of PTPα on Cell Growth-To determine the effects of the expression
of PTPα on cell proliferation, equal amounts (10 5 cells/well) of cells were plated and cultured in the presence of 10% FBS. The medium was changed at 48 h intervals and cells were trypsinized and counted at the indicated times. After a 4 day lag there was a rapid increase in cell number from day 4 to 6 with a plateau at day 7 ( Fig. 2A) . M4 and α12, both overexpressing PTPα, showed significantly faster proliferation than L6 cells.
Cell numbers in these lines were already increased above control L6 after 4 days in culture and were more than 2-fold greater by day 6. In contrast, cells harboring either antisense PTPα or double mutant PTPα, AS14, AS22, and DM8, grew significantly more slowly than L6 and cell numbers remained at about 50% of L6 from day 5 onwards (Fig. 2A) 3A , B) and reached the maximum (near 100% fusion) by day 9 (Fig. 3B ). Cells transfected with either antisense PTPα or with the phosphatase-dead double mutant
PTPα showed alignment at day 5 but failed to fuse into myotubes (Fig. 3A) . This apparent lack of differentiation was not due to a lower cell density as myotubes were not observed in these cells even after 10 days. In contrast, formation of myotubes in cells overexpressing PTPα began earlier, by 3 days after the shift to low serum, and reached a maximum at day 8 ( Fig. 3B ). PC10 showed myotube formation at a rate similar to that of wild-type L6.
Muscle differentiation is characterized by an increase in the expression of muscle specific proteins such as myogenin and creatine kinase (25) . To determine whether this effect of 
A PTPα -c-Src signaling pathway is required for L6 cell differentiation-The
observations that the level of PTPα expression altered cell growth and differentiation as well as Src activity in L6 cells raised the possibility that Src was involved in mediating these effects of PTPα. To explore this possibility, the cells were treated with PP2, a specific inhibitor of Src family kinases (42) , and cell growth rate and cell differentiation were determined. A highly selective p38 MAP kinase inhibitor, SB203580, and a specific MAPK kinase inhibitor, PD098059, were also used as controls for these studies. It has been reported that activation of p38 is required for myoblast fusion and myotube formation in C2C12 cells (43) . In contrast, although not all reports are consistent (32), the traditional MAPK/ERK enzymes are involved in cell proliferation but not differentiation (44) . Cells were plated in 6-well plates and inhibitors were added to the medium at day 2 after seeding. The cell growth rate was markedly decreased by PP2 in all cell lines tested, L6, AS14, and M4 ( suppressed myotube formation but not cell growth (Fig. 6 ).
To be certain that PP2 effects were mediated by inhibition of Src we cotransfected L6 or M4 cells with an expression vector for DN-Src (45) along with β-galactosidase (β-gal) as an indicator of transfection. Cells were then grown in differentiation medium for 4 days and myotube formation was observed by microscopy after X-gal staining and fusion index was determined after Giemsa staining. β-gal positive cells in DN-Src transfected cultures showed a marked decrease in myotube formation (Fig.7A ). In these cultures most of the myotubes lacked blue staining. In contrast, myotubes which formed in the cultures tranfected with empty vector (pcDNA3.1) showed β-gal staining (Fig.7B ).
Determination of cell fusion as an index of myotube formation demonstrated a significant reduction in cells transfected with DN-Src (39%) compared with that in cells transfected
with pcDNA3.1 (61%) (Fig.7C) . Assuming a transfection efficiency of 50% (estimated by β-gal staining) myotube formation was decreased by about 70% by DN-Src. These results were substantiated by the complete inhibition of myogenesis in L6 and M4 cells achieved by SU6656 (Fig.7D) , a novel and specific Src kinase inhibitor (46) . The effect of this inhibitor on cell growth was similar to PP2 (data not shown).
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investigated whether an enhanced expression of PTPα and activation of Src occurred during myogenesis in untransfected cells. Parental L6 cells were grown in growth medium and, at 70% confluence, were transferred to differentiation medium. Whole cell lysates were obtained at different days of culture from both myoblasts and myotubes and subjected to immunoblotting analysis for PTPα and Tyr527 dephosphorylated Src. As shown in Fig. 8A , expression of PTPα was low in myoblast cultures at day 2 but was enhanced at day 3 as myoblasts proliferated and cell density was increased. Upon transfer to differentiation medium, expression of PTPα initially remained high and declined by day 3 after transfer (day 6 after seeding) when most myotubes were formed. In contrast, Src activity, determined by SRC2 antibody immunoblots, was not changed in myoblasts but increased and remained elevated in myotubes (Fig. 8A ).
Muscle cell differentiation is known to be accompanied by expression of specific proteins such as myogenin (25) (Fig. 4) and we observed that inhibition of Src kinase activity resulted in inhibition of myotube formation (Fig. 6 ). We thus examined the effect of PP2 on the expression of myogenin. As expected, myogenin expression was significantly increased in day 2 myotubes (day 5 after seeding) compared with that in myoblasts (Fig.   8B ). In contrast, myogenin expression was completely inhibited in cells grown in differentiation medium treated with PP2. This result strongly supports the concept that Src activation is required for muscle differentiation and muscle specific protein expression.
Src activation is required for C2C12 cell differentiation-To determine whether the role
of Src in skeletal muscle differentiation was a unique characteristic of the rat-derived L6
cell line or a more general phenomenon, we tested whether PP2 inhibition of src family kinases could alter differentiation of the mouse skeletal muscle cell line, C2C12. C2C12 cells were grown in DMEM medium supplemented with 10% FBS. Cell differentiation was induced by changing the medium to DMEM supplemented with 2% horse serum and PP2 was added to the differentiation medium. At day 3 after induction of myogenesis, C2C12 myoblasts began to form multinucleated myotubes which was blocked in cells treated with PP2 (Fig. 9) . These results are consistent with a critical role for Src kinase signaling in skeletal muscle differentiation.
DISCUSSION
The cellular functions of the transmembrane protein tyrosine phosphatase, PTPα, are not well defined. Several studies have suggested that it acts as an inhibitor of insulin signaling (7, 47, 48 ). Yet, other reports have not confirmed these actions (8, 10) . We sought to investigate this hypothesis in skeletal muscle, a major insulin target tissue and The effects on differentiation were first noted microscopically and characterized by both a lack of formation of multinucleated myotubes (AS cells and DM cells) and an enhanced rate of fusion (OE cells). Since transmembrane PTPs have been implicated in cell-cell and cell-extracellular matrix interactions (reviewed in 3) and PTP-α has been found to alter cell adhesion properties, it was possible that only the fusion process was altered rather than myogenesis per se. However, other specific markers of skeletal muscle differentiation, namely myogenin and creatine kinase were affected in a similar pattern to myotube formation indicating that the differentiation process was altered.
The process of myoblast differentiation is complex and several signaling mediators have been shown to be involved such as PI-3-kinase, mTOR, p70 s6k and p38 MAPK (29) (30) (31) 44) . Both insulin and the IGFs have been found to stimulate a short burst of proliferation followed by differentiation in myoblast cell lines (26) (27) (28) and are capable of activating these signaling pathways. In this study we did not employ these growth factors to promote differentiation but used a low serum containing medium. Thus, the role of Src in skeletal muscle differentiation has not been clearly established.
The findings in our cell lines of a correlation of altered Src activity with myoblast differentiation allowed us to examine whether these were related. Inhibition of Src with PP2 blocked differentiation in parental L6 cells as well as L6 cells overexpressing mouse or human PTPα. The inhibitor PP2 is specific for the Src kinase family and, while we cannot rule out a role for other family members, we could not detect significant expression of fyn in our L6 lines (not shown). In addition to PP2, a novel inhibitor of Src kinase, SU6656, also blocked differentiation. Third, transient transfection of DN-Src just prior to onset of differentiation inhibited myotube formation by 70%. We also noted that PP2 and SU6656 blocked the more modest effect of PTPα overexpression on cell proliferation consistent with roles for Src family kinases in both growth and differentiation (56, 57) . As controls, we noted that inhibition of MEK, the upstream activator of ERKs 1 and 2, with PD 098059 only blocked cell proliferation and not differentiation, while inhibition of p38 with SB 203580 had opposite effects, blocking differentiation but not proliferation. These results are consistent with previous studies (30, 44) . Taken together, the data indicate that a previously undescribed PTPα-c-Src signaling pathway is essential for myoblast differentiation.
Two questions raised by these findings are the mechanism by which PTPα is activated in the early differentiation program to recruit Src and the precise role or signaling pathway stimulated by Src in this process. A putative "activating" ligand for PTPα has not been reported and in contrast to receptor PTKs, dimerization of PTPα inhibits its activity (58) .
Recently, in brain and neuronal cells, PTPα has been found to complex with the GPIlinked receptor contactin (59) . Complex formation between contactin and the Src family kinase fyn was previously demonstrated (60) and thus it was proposed that PTPα may provide the link. Contactin participates in the regulation of neuronal migration in the developing brain (60, 61) . One might speculate that a similar GPI-linked protein may be involved in PTPα-Src signaling in differentiating myoblasts.
The target of Src in developing muscle remains unclear. In the case of neuronal cell differentiation, distinct signals mediated by both ras and Src were shown to be required (62) . In skeletal muscle C2C12 cells, a transmembrane disintegrin and metalloprotease termed ADAM12 was recently described to be upregulated during differentiation (63, 64) and to be associated via its proline-rich cytoplasmic domains with the SH3 domain of Src confluence by changing the medium to a differentiation medium supplemented with 2% horse serum. PP2 (10 µM) was added to the culture following induction of myogenesis.
Cell differentiation was monitored microscopically and photographed on day 3 after induction as described in Fig. 3 . 
